New Expansion at Alderley Park

An expansion planned at the UK’s Alderley Park will result in a new facility for the drug research firm Sygnature Discovery which will double their drug metabolism and pharmacokinetics (DMPK) department.

The expansion will be carried out at both Sygnature sites: Alderley Park and Nottingham, England. Within the expansion, the firm plans on carrying out a sustained recruitment programme.

Chief operating officer Dr. Jonathan Williams said “The North West has a wealth of expertise in the field of DMPK and as Alderley Park is home to the UK’s largest life science campus we wanted to align our growth with theirs”.

This full day of interactive workshops and talks will showcase tangible mechanisms for facilitating stakeholder interaction to ensure science’s impact on society and the markets. Expect valuable insights from both Academia and Industry, with keynote speeches from the Dr John C Taylor Professor of Innovation at the University of Cambridge and Head of the Institute[...]

EDUCATION – Plan on must attend, highly interactive modules addressing professional and leadership development. INFORMATION EXCHANGE – A week full of intense networking and collaborating opportunities which include the VIP AURP Board of Directors’ Sponsor Appreciation Dinner, group meals in the courtyard, informal evening dinners and tours. AFFORDABILITY – A lifetime worth of knowledge offered in a one-week[...]

NEED HELP?

ADDRESS

CALL US

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.